L. Mesana

446 total citations
20 papers, 290 citations indexed

About

L. Mesana is a scholar working on Economics and Econometrics, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, L. Mesana has authored 20 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 4 papers in Surgery and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in L. Mesana's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Inflammatory Bowel Disease (4 papers) and Cardiac Valve Diseases and Treatments (2 papers). L. Mesana is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Inflammatory Bowel Disease (4 papers) and Cardiac Valve Diseases and Treatments (2 papers). L. Mesana collaborates with scholars based in United States, Belgium and Canada. L. Mesana's co-authors include Thierry Mesana, Marc Ruel, Maud Pacou, Lina Chen, Vincent Chan, Mario Castro, Roy G. Masters, Thomas B. Casale, Dai Une and Shawn X. Sun and has published in prestigious journals such as Circulation, Biomaterials and The American Journal of Gastroenterology.

In The Last Decade

L. Mesana

19 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Mesana United States 8 105 93 65 61 40 20 290
Franziska Peters Germany 9 116 1.1× 50 0.5× 28 0.4× 102 1.7× 24 0.6× 26 449
Juan González‐Moreno Spain 10 88 0.8× 125 1.3× 43 0.7× 60 1.0× 18 0.5× 43 317
Yukiko Takahashi Japan 9 24 0.2× 51 0.5× 96 1.5× 95 1.6× 22 0.6× 22 359
I. Febrer Spain 13 19 0.2× 91 1.0× 26 0.4× 56 0.9× 86 2.1× 35 359
Margot Nash Australia 6 127 1.2× 38 0.4× 225 3.5× 214 3.5× 23 0.6× 11 376
Ünsal Özgen Türkiye 11 48 0.5× 43 0.5× 30 0.5× 24 0.4× 5 0.1× 32 282
Alexandre Lockhart United States 12 21 0.2× 143 1.5× 78 1.2× 81 1.3× 43 1.1× 19 403
Jayakanthan Kabeerdoss India 11 23 0.2× 41 0.4× 132 2.0× 184 3.0× 21 0.5× 32 427
Fionnuala Mone United Kingdom 17 57 0.5× 78 0.8× 44 0.7× 72 1.2× 16 0.4× 60 666
Mark Lega United States 6 25 0.2× 114 1.2× 97 1.5× 169 2.8× 49 1.2× 13 310

Countries citing papers authored by L. Mesana

Since Specialization
Citations

This map shows the geographic impact of L. Mesana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Mesana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Mesana more than expected).

Fields of papers citing papers by L. Mesana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Mesana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Mesana. The network helps show where L. Mesana may publish in the future.

Co-authorship network of co-authors of L. Mesana

This figure shows the co-authorship network connecting the top 25 collaborators of L. Mesana. A scholar is included among the top collaborators of L. Mesana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Mesana. L. Mesana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merola, Joseph F., Soumya D. Chakravarty, L. Mesana, et al.. (2021). Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA–a retrospective study of claims data from 2009 to 2020. Clinical Rheumatology. 40(10). 4061–4070. 18 indexed citations
2.
Orbai, Ana‐Maria, Soumya M. Reddy, Steven L. Peterson, et al.. (2021). Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA—a retrospective study of claims data from 2009 TO 2020. Clinical Rheumatology. 40(12). 4933–4942. 17 indexed citations
3.
4.
Benson, Carmela, Kirsty Dunn, L. Mesana, et al.. (2020). Antiretroviral Adherence, Drug Resistance, and the Impact of Social Determinants of Health in HIV-1 Patients in the US. AIDS and Behavior. 24(12). 3562–3573. 38 indexed citations
5.
Peterson, Steven L., et al.. (2020). PMU15 RETROSPECTIVE STUDY EXAMINING HEALTH CARE UTILIZATION AND COSTS FOR PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS IN THE US. Value in Health. 23. S235–S235. 2 indexed citations
6.
7.
Constantin, Jean‐Michel, et al.. (2018). PDB14 - MOBILE APPS FOR MEDICATION ADHERENCE IN DIABETES. Value in Health. 21. S121–S121. 1 indexed citations
8.
Casale, Thomas B., et al.. (2018). Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 7(1). 122–130.e1. 41 indexed citations
9.
Mesana, L., et al.. (2018). Patient Involvement in Health Technology Assessments: An International Comparison. Value in Health. 21. S54–S54. 1 indexed citations
10.
Mesana, L., et al.. (2018). PMD165 - EVALUATING DIGITAL HEALTH TECHNOLOGIES: A REVIEW OF HTA GUIDANCE AND ASSESSMENTS IN EUROPE. Value in Health. 21. S271–S271. 2 indexed citations
11.
Mesana, L., et al.. (2018). Value-Based Health Care in Asia: Outcomes From Taiwan's Pay-For-Performance Programs. Value in Health. 21. S54–S54. 2 indexed citations
12.
Pacou, Maud, L. Mesana, A. Gauthier, et al.. (2017). PTH-094 Indirect treatment comparison of ustekinumab versus other biologics in moderate to severe crohn’s disease: a 1-year treatment sequence analysis. HighWire Press Open Archive. A253.1–A253. 1 indexed citations
13.
14.
Belhadi, Drifa, Maud Pacou, A. Gauthier, V. Taieb, & L. Mesana. (2016). Checklist To Assess The Feasibility Of A Network Meta-Analysis. Value in Health. 19(3). A100–A100. 1 indexed citations
15.
Pacou, Maud, L. Mesana, A. Gauthier, et al.. (2016). Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease: A 1-Year Treatment Sequence Analysis. Value in Health. 19(7). A576–A576. 7 indexed citations
16.
Marcoux, Isabelle, Antoine Boivin, L. Mesana, Ian D. Graham, & Paul Hébert. (2016). Medical end-of-life practices among Canadian physicians: a pilot study. CMAJ Open. 4(2). E222–E229. 6 indexed citations
17.
Pacou, Maud, V. Taieb, Drifa Belhadi, L. Mesana, & A. Gauthier. (2015). Interpreting Results from Bayesian Network Meta-Analyses (Nma): A Guide for Non-Statisticians. Value in Health. 18(7). A718–A719. 3 indexed citations
18.
Une, Dai, L. Mesana, Vincent Chan, et al.. (2015). Clinical Impact of Changes in Left Ventricular Function After Aortic Valve Replacement. Circulation. 132(8). 741–747. 59 indexed citations
19.
Ahmadi, Ali, Brian McNeill, Branka Vulesevic, et al.. (2014). The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium. Biomaterials. 35(17). 4749–4758. 26 indexed citations
20.
Chan, Vincent, Lina Chen, L. Mesana, Thierry Mesana, & Marc Ruel. (2011). Heart valve prosthesis selection in patients with end-stage renal disease requiring dialysis: a systematic review and meta-analysis. Heart. 97(24). 2033–2037. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franziska Peters Breakdown of academic impact, for papers by Juan González‐Moreno Breakdown of academic impact, for papers by Yukiko Takahashi Breakdown of academic impact, for papers by I. Febrer Breakdown of academic impact, for papers by Margot Nash Breakdown of academic impact, for papers by Ünsal Özgen Breakdown of academic impact, for papers by Alexandre Lockhart Breakdown of academic impact, for papers by Jayakanthan Kabeerdoss Breakdown of academic impact, for papers by Fionnuala Mone Breakdown of academic impact, for papers by Mark Lega
Rankless by CCL
2026